Açıklama
Gene expression profiling of lipid metabolism-related genes following melatonin treatment in prostate cancer cells. Several key regulators of cholesterol and fatty acid synthesis appear downregulated.
Figure 9
ChartSource Paper
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.Cite This Figure
![Figure 9: Gene expression profiling of lipid metabolism-related genes following melatonin treatment in prostate cancer cells. Several key regulators of cholesterol and fatty acid synthesis appear downregulated.]() > Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." *Clinical and translational medicine*, 2021. PMID: [34185414](https://pubmed.ncbi.nlm.nih.gov/34185414/)
<figure> <img src="" alt="Gene expression profiling of lipid metabolism-related genes following melatonin treatment in prostate cancer cells. Several key regulators of cholesterol and fatty acid synthesis appear downregulated." /> <figcaption>Figure 9. Gene expression profiling of lipid metabolism-related genes following melatonin treatment in prostate cancer cells. Several key regulators of cholesterol and fatty acid synthesis appear downregulated.<br> Source: Lijie Zhou et al. "Melatonin inhibits lipid accumulation to repress prostate cancer progression by ." <em>Clinical and translational medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34185414/">34185414</a></figcaption> </figure>